Just the Facts on General Motors Company (GM)

General Motors Company (GM) is an interesting player in the Consumer Goods space, with a focus on Auto Manufacturers – Major. The stock has been active on the tape, currently trading at $38.01, up from yesterday’s close by 0.48%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

General Motors Company (GM) currently trades with a market capitalization of $53.99 Billion. That value represents a market adjusting for revenues that have been falling by -5.47 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of -$10.3 Billion over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $1.3 on a per share basis this quarter. Perhaps, that suggests something about why 0.16% of the outstanding share supply is held by institutional investors.



Technical Analysis

It’s important to check the technicals to get a sense of how GM has been acting. Looking at the stock’s movement on the chart, General Motors Company recorded a 52-week high of $46.76. It is now trading 8.75% off that level. The stock is trading $41.52 its 50-day moving average by 3.51%. The stock carved out a 52-week low down at $31.92.

In recent action, General Motors Company (GM) has made a move of -9.50% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 16.68, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 2.50% with $1.32 Billion sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of GM.

SHARE
Previous articleThe Case for and Against Endocyte, Inc. (ECYT)
Next articleTaking a Look at the Data Behind Citigroup Inc. (C)